Media & Resources

IAVI partnered with National AIDS and STI Control Program (NASCOP) in Kenya to produce a documentary film on mapping and size estimation of key populations of people living with HIV. This film provides useful information for stakeholders including communities of key populations, policymakers, civil society organizations, researchers, and funders specifically on who are the key populations, where they are in terms of hotspots and geographical areas, the size of these populations, and their numbers. Additionally, this documentary film provides a best practice for Africa on how other countries can innovatively conduct mapping and size estimation for and with key populations in Africa.

When you get a messenger RNA (mRNA) vaccine, your body receives the blueprint and all the instructions it needs to protect you. Watch this video to learn how mRNA vaccines are designed to teach our bodies to respond to a virus. Learn more at iavi.org.

Antibodies are natural proteins that the body makes that fight disease. Broadly neutralizing antibodies (bnAbs) are a special kind of antibody that is now being researched to see how they can play a role in HIV prevention. IAVI translates scientific discoveries into affordable, globally accessible public health solutions, and we believe all people should have access to innovative medicines.

It all began with the mission to accelerate the development of safe, effective AIDS vaccines for use throughout the world. Today, we remain dedicated to our search for an HIV vaccine, while applying all that we have learned to translate scientific discoveries into affordable, globally accessible public health solutions for other major challenges. In 2021, as IAVI turned 25, we reflected on all we and our partners have accomplished and what the future holds for IAVI and global health research.

It all began with the mission to accelerate the development of safe, effective AIDS vaccines for use throughout the world. Today, we remain dedicated to our search for an HIV vaccine, while applying all that we have learned to translate scientific discoveries into affordable, globally accessible public health solutions for other major challenges. In 2021, as IAVI turned 25, we reflected on all we and our partners have accomplished and what the future holds for IAVI and global health research.

Despite great progress in HIV prevention and in treatment using antiretroviral therapy, there are still almost 40 million people living with HIV globally. Our best long-term hope to end the HIV/AIDS pandemic is a safe, effective, preventive vaccine that can be used worldwide.

An overview of the process of HIV vaccine development and the many steps that a vaccine has to pass in order to guarantee it’s safe and effective to use.

Six women living in South Africa share their journeys to navigate relationships with men, cultural and gendered norms, pregnancy and child-rearing, and violence against women in the context of HIV risk.